Breaking Down Malion New Materials Co., Ltd. Financial Health: Key Insights for Investors

CN | Basic Materials | Chemicals - Specialty | SHZ

Malion New Materials Co., Ltd. (300586.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Dive into a data-driven look at Malion New Materials Co., Ltd. (300586.SZ) where the quarter ending June 30, 2025 shows revenue of ¥430.05 million (down 0.26% QoQ) against a trailing twelve months (TTM) revenue of ¥1.76 billion (YoY +0.09%), set against 2024 annual revenue of ¥1.73 billion (‑7.55%); note a workforce of 1,091 yielding revenue per employee of ¥1.61 million and a market valuation with market cap at ¥7.45 billion (up 74.79% YoY) and enterprise value of ¥8.51 billion, while profitability metrics reveal TTM net margin of 2.07%, gross margin of 7.46%, quarterly EBITDA of ¥217.57 million but a quarterly net loss of ‑¥21.01 million and EPS of ‑¥0.0359, balance-sheet figures show total assets of ¥3,678.73 million against liabilities of ¥844.42 million (debt/equity ~40%), cash and equivalents at ¥265.49 million (down 18.94%), quarter cash flow from operations ¥17 million and net change in cash ‑¥43.70 million, while valuation multiples include P/S 4.02, P/B 4.13 and P/E of ‑204.07, and key solvency and liquidity ratios alongside ROE of ‑3.04% and other metrics raise immediate questions for investors seeking upside amid clear risks and potential growth vectors

Malion New Materials Co., Ltd. (300586.SZ) Revenue Analysis

Key top-line metrics for Malion New Materials Co., Ltd. show near-stable short-term sales with modest annual movement and an elevated market valuation relative to revenue.

  • Quarter (ending 2025-06-30) revenue: ¥430.05 million (q/q change: -0.26%).
  • Trailing twelve months (TTM) revenue: ¥1.76 billion (y/y growth: +0.09%).
  • Full-year 2024 revenue: ¥1.73 billion (year-over-year decline: -7.55%).
  • Revenue per employee: ≈ ¥1.61 million (1,091 employees).
  • Price-to-Sales (P/S) ratio: 4.02.
  • Market capitalization (2025-10-24): ¥7.45 billion (+74.79% over past year).
Metric Value Period / Note
Quarterly Revenue ¥430.05 million Quarter ended 2025-06-30 (q/q -0.26%)
TTM Revenue ¥1.76 billion Trailing twelve months (y/y +0.09%)
Annual Revenue (2024) ¥1.73 billion 2024 (y/y -7.55%)
Employees 1,091 Headcount
Revenue per Employee ¥1.61 million TTM / headcount
Price-to-Sales (P/S) 4.02 Market valuation metric
Market Capitalization ¥7.45 billion As of 2025-10-24 (+74.79% YoY)

Implications and context for investors:

  • Stability: Quarterly revenue decline is marginal (-0.26%), indicating stable demand in the near term.
  • Stagnant TTM growth: TTM up only 0.09% suggests limited organic revenue expansion over the past year.
  • 2024 contraction: A 7.55% revenue drop in 2024 points to a notable slowdown that has only partially recovered.
  • Productivity: Revenue per employee (~¥1.61M) can be compared to peers to assess operational efficiency.
  • Valuation caution: P/S of 4.02 and a market cap that rose 74.79% in the past year imply market optimism-assess whether earnings, margins, or growth justify the premium.

For background on the company's history, ownership and business model, see: Malion New Materials Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Malion New Materials Co., Ltd. (300586.SZ) Profitability Metrics

Key profitability indicators for Malion New Materials Co., Ltd. (300586.SZ) reveal a company with modest gross profitability but recent net losses and negative shareholder returns. The data below highlights margins, returns, and per-share results that investors should weigh alongside operational cash-flow figures.

  • Trailing twelve months (TTM) net profit margin: 2.07% (positive but modest).
  • Return on equity (ROE): -3.04% (negative, indicating equity erosion in the period).
  • Latest quarter EPS (quarter ending 2025-06-30): -¥0.0359 (loss per share).
  • Latest quarter net income: -¥21.01 million (net loss reported).
  • TTM gross profit margin: 7.46% (revenue above COGS by this percentage).
  • Latest quarter EBITDA: ¥217.57 million (operational profitability proxy).
Metric Value Period
Net Profit Margin (TTM) 2.07% Trailing 12 months
Gross Profit Margin (TTM) 7.46% Trailing 12 months
Return on Equity (ROE) -3.04% Latest reported
EPS -¥0.0359 Quarter ending 2025-06-30
Net Income -¥21.01 million Quarter ending 2025-06-30
EBITDA ¥217.57 million Quarter ending 2025-06-30

Investors seeking broader context on ownership, trading activity, and investor drivers can follow additional company profile material here: Exploring Malion New Materials Co., Ltd. Investor Profile: Who's Buying and Why?

Malion New Materials Co., Ltd. (300586.SZ) Debt vs. Equity Structure

Malion New Materials maintains a moderate leverage profile with a debt-to-equity ratio of 40%, reflecting measured use of debt alongside shareholders' equity. Key balance-sheet and market metrics frame how the company's capital structure and valuation interact.
  • Debt-to-Equity Ratio: 40% - moderate leverage, not overly aggressive.
  • Total Liabilities: ¥844.42 million - the absolute quantum of obligations on the balance sheet.
  • Total Assets: ¥3,678.73 million - supporting asset base versus liabilities.
  • Enterprise Value: ¥8.51 billion - market value plus net debt, capturing total corporate value.
  • Market Capitalization: ¥7.45 billion - market's valuation of equity.
  • Price-to-Book (P/B): 4.13 - market price ~4.13x book value, indicating growth/valuation premium.
  • Net Change in Cash (Latest Quarter): -¥43.70 million - a quarter-over-quarter cash decrease.
Metric Value
Debt-to-Equity Ratio 40%
Total Liabilities ¥844.42 million
Total Assets ¥3,678.73 million
Enterprise Value ¥8.51 billion
Market Capitalization ¥7.45 billion
Price-to-Book (P/B) 4.13
Net Change in Cash (Latest Quarter) -¥43.70 million
  • Relative leverage: With liabilities of ¥844.42M against assets of ¥3,678.73M, the balance sheet retains substantial equity coverage.
  • Valuation tension: EV (¥8.51B) modestly exceeds market cap (¥7.45B), reflecting net debt and investor valuation of future cash flows.
  • Liquidity watch: Quarterly cash decline of ¥43.70M warrants monitoring of operating cash flow and financing activity.
  • Investor perspective: P/B of 4.13 signals expectations of above-book returns or intangible value drivers priced in by the market.
Exploring Malion New Materials Co., Ltd. Investor Profile: Who's Buying and Why?

Malion New Materials Co., Ltd. (300586.SZ) - Liquidity and Solvency

  • Cash and cash equivalents (Mar 2025): ¥265.49 million (down 18.94% vs. prior period)
  • Cash flow from operations (Q2 Jun 2025): ¥17 million
  • Net income from continuing operations (Q2 Jun 2025): -¥37 million (loss)
  • Total assets: ¥3,678.73 million
  • Total liabilities: ¥844.42 million
  • Current ratio: not specified (important for short-term liquidity assessment)
  • Quick ratio: not specified (important for immediate liquidity assessment)
Metric Amount (¥ million) Notes
Cash & cash equivalents (Mar 2025) 265.49 -18.94% vs. prior period
Cash flow from operations (Q2 Jun 2025) 17.00 Positive operating cash generation
Net income from continuing operations (Q2 Jun 2025) -37.00 Quarterly loss
Total assets 3,678.73 Balance-sheet scale
Total liabilities 844.42 Solvency context
Current ratio Not specified Requires current assets/current liabilities
Quick ratio Not specified Requires inventory exclusion
  • Solvency view: with total assets of ¥3,678.73 million against liabilities of ¥844.42 million, the company shows a sizable asset base relative to obligations, but precise short-term coverage requires current/quick ratios.
  • Liquidity dynamics: cash fell ~19% to ¥265.49 million while operating cash was modestly positive at ¥17 million for the quarter-this juxtaposition alongside a quarterly net loss (-¥37 million) signals reliance on working capital management and other funding sources to sustain operations.
  • Key monitoring items for investors:
    • Levels of current assets and current liabilities to compute current and quick ratios
    • Trend in operating cash flow vs. net income to assess quality of earnings
    • Inventory levels and receivables aging to estimate quick ratio and near-term cash conversion
Exploring Malion New Materials Co., Ltd. Investor Profile: Who's Buying and Why?

Malion New Materials Co., Ltd. (300586.SZ) Valuation Analysis

Key valuation and profitability metrics for Malion New Materials Co., Ltd. (300586.SZ) highlight a mixed picture: market valuation multiples are elevated while profitability metrics show pressure from negative earnings and weak returns to shareholders.

  • Price-to-Earnings (P/E): -204.07 - negative due to reported net losses over the trailing period, signaling lack of profitability on an earnings-per-share basis.
  • Price-to-Book (P/B): 4.13 - the market values equity at just over four times book value, implying growth or intangible-value premium priced in by investors.
  • Enterprise Value (EV): ¥8.51 billion - reflects total firm value including debt and minority interests.
  • Market Capitalization: ¥7.45 billion - the market price value of outstanding shares at the reported snapshot.
  • Net Profit Margin (TTM): 2.07% - positive but modest margin, indicating slight profitability on sales in the trailing twelve months.
  • Return on Equity (ROE): -3.04% - negative, showing the company generated a loss relative to shareholders' equity over the period.
Metric Value Interpretation
P/E Ratio -204.07 Negative EPS; traditional P/E multiple not meaningful for forecasting without adjusted earnings.
P/B Ratio 4.13 High relative to book suggests market expects future returns or carries intangible/strategic value.
Enterprise Value (EV) ¥8.51 billion Combined equity and net debt valuation used for takeover or comparables analysis.
Market Capitalization ¥7.45 billion Equity market valuation at current share price.
Net Profit Margin (TTM) 2.07% Modest operating profitability; margins are positive but narrow.
Return on Equity (ROE) -3.04% Negative return indicates equity value was eroded over the period.

Key valuation trade-offs for investors to weigh:

  • High P/B amid negative P/E and negative ROE suggests investors are pricing potential recovery, growth opportunities, or asset repricing rather than current earnings power.
  • EV vs. market cap (EV ¥8.51B vs. market cap ¥7.45B) indicates net debt or other non-equity claims contribute meaningfully to enterprise value.
  • Modest net profit margin (2.07%) contrasts with negative ROE, implying profitability may be concentrated in revenue lines but offset by balance-sheet or non-operating losses.

Further context on ownership, recent filings, and investor interest can be found here: Exploring Malion New Materials Co., Ltd. Investor Profile: Who's Buying and Why?

Malion New Materials Co., Ltd. (300586.SZ) - Risk Factors

Malion New Materials reported a net loss for the latest quarter, with several financial indicators signaling short-term stress and investor risk.
  • Net income (latest quarter): -¥21.01 million.
  • EPS (quarter ending 2025-06-30): -¥0.0359.
  • Return on equity (ROE): -3.04%.
  • Debt-to-equity ratio: 40% (moderate leverage).
  • Total liabilities: ¥844.42 million vs. total assets: ¥3,678.73 million (liabilities ≈ 22.96% of assets).
  • Net change in cash (latest quarter): -¥43.70 million (cash reserves decreased).
Metric Value Notes
Net Income (latest quarter) -¥21.01 million Quarterly loss reduces retained earnings and equity growth
Earnings Per Share (EPS) -¥0.0359 Negative EPS dilutes shareholder returns
Return on Equity (ROE) -3.04% Negative profitability on shareholder capital
Debt-to-Equity Ratio 40% Moderate leverage; interest/service obligations present
Total Assets ¥3,678.73 million Asset base available to cover liabilities
Total Liabilities ¥844.42 million Obligations that must be managed and serviced
Liabilities / Assets 22.96% Indicates balance-sheet solvency cushion
Net Change in Cash (quarter) -¥43.70 million Decline in cash could constrain operations or require financing
  • Profitability risk: negative net income, EPS, and ROE point to operational or margin pressures that may persist absent turnaround measures.
  • Liquidity risk: a ¥43.70 million decrease in cash in the quarter raises short-term funding concerns if cash outflows continue.
  • Leverage risk: while debt-to-equity at 40% is moderate, interest costs and covenant exposure remain potential issues if profits stay negative.
  • Balance-sheet considerations: total liabilities of ¥844.42 million against assets of ¥3,678.73 million imply coverage today, but continued losses can erode this buffer.
  • Market and execution risk: sustained negative ROE and EPS may impair investor confidence, share price performance, and access to capital.
For historical context and broader company background, see: Malion New Materials Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Malion New Materials Co., Ltd. (300586.SZ) - Growth Opportunities

Malion New Materials presents a mixed financial profile with clear avenues for growth alongside structural challenges. Key headline figures frame the investment thesis and immediate operational levers:

Metric Value
Market Capitalization ¥7.45 billion
Enterprise Value (EV) ¥8.51 billion
Net Profit Margin (TTM) 2.07%
Return on Equity (ROE) -3.04%
Earnings Per Share (Q2 2025) -¥0.0359
Debt-to-Equity Ratio 40%
  • Market valuation vs. enterprise value: EV/Market Cap ≈ 1.14, indicating debt and minority interests add modestly to total valuation - important when assessing takeover or capital restructure scenarios.
  • Positive net profit margin (2.07%) shows operational profitability at scale, but low margin leaves limited buffer for margin compression or cyclical downturns.
  • Negative ROE (-3.04%) and negative EPS for Q2 2025 point to recent earnings stress - likely driven by one-off items, price pressure, or elevated operating costs; these require remediation to restore shareholder return.
  • Debt-to-equity at 40% signals a moderate leverage position that can support expansion but may constrain aggressive M&A or capex without refinancing or equity raises.

Concrete growth avenues for Malion New Materials include:

  • Product mix optimization toward higher-margin specialty materials to lift net profit margin and convert modest profitability into meaningful EPS recovery.
  • Operational efficiency measures (capex in automation, procurement rationalization) aimed at improving gross and operating margins given existing positive net margin.
  • Targeted geographic expansion and downstream integration to capture more value along the supply chain, supported by the company's current moderate leverage capacity.
  • Selective partnerships or licensing for advanced materials to accelerate technology adoption without materially increasing balance-sheet risk.

Key financial sensitivities investors should monitor:

  • Quarterly EPS trajectory: recovering from -¥0.0359 in Q2 2025 would be a strong signal that margin and cost initiatives are working.
  • ROE trend: moving from negative to positive requires both earnings improvement and disciplined capital allocation.
  • Leverage management: keeping debt-to-equity near 40% or lowering it can preserve financial flexibility while funding growth.

For context on corporate direction and strategic priorities that inform these growth opportunities, see Mission Statement, Vision, & Core Values (2026) of Malion New Materials Co., Ltd.

DCF model

Malion New Materials Co., Ltd. (300586.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.